Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 26, Issue 3, 2008, Pages 300-316

  Krishnan, Kannan ^a   Carrier, Richard ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

Aggregate exposure; Dermal; Inhalation; Multiroute; Pharmacokinetics; VOCs

Indexed keywords

CONCENTRATION (PROCESS); REUSABILITY; SKIN; WATER POLLUTION;

AGGREGATE EXPOSURE; AIR-TO-WATER; BREATHING RATE; CHEMICAL CONTAMINANTS; DERMAL; DERMAL EXPOSURE; DRINKING WATER; EXPOSURE GUIDELINES; EXPOSURE PARAMETERS; GUIDELINE VALUES; INHALATION; INHALATION EXPOSURES; MODELIN G STUDIES; MULTIROUTE; ORAL ROUTE; PHARMACOKINETICS; SKIN PERMEABILITY; TOTAL-DOSE; VOCS; WATER INTAKES;

POTABLE WATER;

DRINKING WATER;

BREATHING RATE; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; HUMAN; MATHEMATICAL MODEL; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; REVIEW; SKIN PERMEABILITY; WATER CONTAMINATION;

ADOLESCENT; ADULT; AGE FACTORS; BATHS; CANADA; CHILD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GUIDELINES AS TOPIC; HUMANS; INHALATION EXPOSURE; MODELS, BIOLOGICAL; RISK ASSESSMENT; SKIN ABSORPTION; TIME FACTORS; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION; WATER PURIFICATION; WATER SUPPLY;

EID: 51849109964     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590500802343974     Document Type: Review

References (59)

1. Brown HS, Bishop DR, Rowan CA. The role of skin absorption as a route of exposure for volatile organic compounds (VOCs) in drinking water. Am J Pub Health 1984; 74:479-484.
2. Andelman JB. Inhalation exposure in the home to volatile organic contaminants of drinking water. Sci Total Environ 1985; 47:443-460.
3. McKone TE. Human exposure to volatile organic compounds in household tap water: The indoor inhalation pathway. Env Sci Technol 1987; 21:1194-1201.
4. Jo WK., Weisel CP, Lioy PJ. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Anal 1990a; 10 (4):581-585.
5. Jo WK, Weisel CP, Lioy PJ. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal 1990b; 10 (4):575-580.
6. Maxwell NI, Burmaster DE, Ozonoff D. Trihalomethanes and maximum contaminant levels: The significance of inhalation and dermal exposures to chloroform in household water. Regul Toxicol Pharmacol 1991; 14:297-312.
7. McKone TE, Knezovich JP. The transfer of trichloroethylene (TCE) from a shower to indoor air: experimental measurements and their implications. J Air Waste Manage Assoc 1991; 41:282-286.
8. Shatkin JA, Brown HS. Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: a computer simulation model. Environ Res 1991; 56:90-108.
9. Lindstrom AB, Pleil JD. A methodological approach for exposure assessment studies in residence using volatile organic compound-contaminated water. J AirWaste Manage Assoc 1996; 46:1058-1066.
10. Weisel CP, Jo WK. Ingestion, Inhalation and dermal exposures to chloroform and trichloroethene from tap water. Environ Health Perspect 1996; 104:48-51.
11. Kim E, Little JC, Chiu N, Chiu A. Inhalation exposure to volatile chemicals in drinking water. Environ Carcino Ecotox Revs 2001; C19 (2):387-413.
12. Bogen KT. Models based on steady-state in vitro dermal permeability data underestimate short-term in vivo exposures to organic chemicals in water. J Exp Anal Environ Epidemiol 1994; 4:457-475.
13. Kezic S, Monster AC, Kruse J, Verberk MM. Skin absorption of some vaporous solvents in volunteers. Int Arch Occup Environ Health 2000; 73:415-422.
14. Jones K, Cocker J, Dodd LJ, Fraser I. Factors affecting the extent of dermal absorption of solvent vapours: A human volunteer study. Ann Occup Hyg 2003; 47:145-150.
15. Thrall K, Woodstock A. Evaluation of the dermal bioavailability of aqueous xylene in F344 rats and human volunteers. J Toxicol Environ Health A 2003; 66:1267-1281.
16. Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol 2002; 184:19-26.
17. Xu X, Weisel CP. Dermal uptake of chloroform and haloketones during bathing. J Expo Anal Environ Epidemiol 2005a; 15:289-96.
18. Xu X, Weisel CP. Human respiratory uptake of chloroform and haloketones during showering. J Expo Anal Environ Epidemiol 2005b; 15:6-16.
19. Clewell HJ III, Andersen ME. Dose, species and route extrapolation using physiologically-based pharmacokinetic models. Drinking Water and Health 1987; 8:159-182.
20. Krishnan K, Andersen ME. Physiologically-based pharmacokinetic modeling. In toxicology. In Principles and Methods of Toxicology, 4th ed. (pp. 193-241), Hayes AW (Ed.). Taylor & Francis: Philadelphia, PA; 2001.
21. U.S. EPA. Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. Washington, D.C., U.S. Environmental Protection Agency, National Center for Environmental Assessment 2006, EPA/600/R-05/043F.
22. Gerrity TR, Henry CJ, Birnbaum L. Principles of route-to-route extrapolation for risk assessment, 1st ed., Gerrity TR, Henry CJ, (Eds.). New York: Elsevier; 1990.
23. Lipscomb JC, Ohanian EV (Eds.). Toxicokinetics and Risk Assessment. New York: Infarma press; 2006.
24. Blancato JN, Chiu N. Predictive modeling for uptake and tissue distribution from human exposures. In Safety of Water Disinfection: Balancing Chemical & Microbial Risks, 1st ed. (pp. 303-316), Craun G. (Ed.). Washington, D.C.: ILSI Press; 1993.
25. Rao HV, Ginsberg GL. A physiologically-based pharmacokinetic model assessment of methyl t-butyl ether in groundwater for a bathing and showering determination. Risk Anal 1997; 17 (5):583-598.
26. Corley RA, Gordon SM, Wallace LA. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicol Sci 2000; 53 (1):13-23.
27. Levesque B, Ayotte P, Tardif R, Ferron L, Gingras S, Schlouch E, Gingras G, Levallois P, Dewailly E. Cancer risk associated with household exposure to chloroform. J Toxicol Environ Health Part A 2002; 65:489-502.
28. Krishnan K. Evaluation of the relative importance of dermal and inhalation routes of exposure for trichloroethylene. Report submitted to Water Quality and Health Bureau, Safe Environments Programme, Health Canada; 2003.
29. Krishnan K. Evaluation of the relative importance of dermal and inhalation routes of exposure for developing drinking water guidelines for trihalomethanes. Report submitted to Water Quality and Health Bureau, Safe Environments Programme, Health Canada; 2003.
30. Haddad S, Charest Tardif G, Tardif R. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: Trichloroethylene and trihalomethanes. J Toxicol Environ Health Part A 2006; 69:2095-2136.
31. Tan Y-M, Liao KH, Conolly RB, Blount BC, Mason AM, Clewell HJ. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J Toxicol Environ Health Part A 2006; 69:1727-1756.
32. Levesque B, Ayotte P, Tardif R, Charest-Tardif G, Dewailly E, Prud'Homme D, Gingras G, Allaire S, Lavoie R. Evaluation of the health risk associated with exposure to chloroform in indoor swimming pools. J Toxicol Environ Health A 2000; 61 (4):225-243.
33. U.S. EPA. Risk assessment guidance for superfund (RAGS). In Human health evaluation manual, Interim draft. Washington, D.C. U.S. Environmental Protection Agency, Office of Emergency and Remedial Response, 1998; Volume I (part E, Supplemental guidance for dermal risk assessment), P A-31.
34. De Heer C, Wilschut A, Stevenson H, Hakkert BC. Guidance document of the estimation of dermal absorption according to a tiered approach: An update. TNO Report V98.1237. Zeist, the Netherlands: TNO Nutrition and Food Research Institute; 1999.
35. European Commission. Global net on consumer exposure modelling. Report of the workshop no.1 on: Dermal transfer and penetration algorithms. Kephalopoulos S, van Hemmen JJ, and van der Jagt K. EUR 22521 EN/1. 6. Institute for health and consumer protection; 2004.
36. European Commission. Guidance document on dermal absorption. European commission, health and consumer protection directorate-general, Directorate E-Food Safety: plant health, animal health and welfare, international questions, E1-Plant health Sanco/222/2000 rev.7; 2004:1-15.
37. ACGIH (American Conference of Governmental Industrial Hygienists). TLVs and BEIs. Based on the documentation for threshold limit values for chemical substances and physical agents. Cincinnati: ACGIH, Cincinnati; 1999.
38. Sartorelli P, Ahlers HW, Alanko K, Chen-Peng C, Cherrie JW, Drexler H, Kezic S, Johanson G, Larese Filon F, Maina G, Montomoli L, Nielsen JB. How to improve skin notation Position paper from a workshop. Reg Toxicol Pharmacol 2007; 49:301-307.
39. SCOEL (Scientific Committee Group on Occupational Exposure Limits). Methodology for the derivation of occupational exposure limits: Key documentation. Luxembourg, European Commission Report EUR 19253 EN; 1999:28.
40. Nakai JS, Stathipulos PB, Campbell GL, Chu I, Muller AL, Aucoin R. Penetration of chloroform, trichloroethylene and tetrachloroethylene through human skin. J Toxicol Environ Health 1999; 58: 157-170.
41. Health Canada. Trichloroethylene in drinking water. Document for public comment. Federal-provincial-territorial committee on drinking water, Ottawa, ON; 2004. (http://hc-sc.gc.ca/hecs/sesc/water/pdf/TCE-Consultation.pdf).
42. Health Canada. Trihalomethanes in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON; 2004.
43. Health Canada. Exposure factors for assessing total daily intake of priority substances by the general population of Canada. Draft. Health Canada, Ottawa, ON; 1998.
44. Kumagai S, Oda H, Matsunaga I, Kosaka H, Akasaka S. Uptake of 10 polar organic solvents during short-term respiration. Toxicol Sci 1999; 48: 255-263.
45. OEHHA. Public health goal for trichloroethylene in drinking water. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency; Feb 1999.
46. Potts RO, Guy RH. Predicting skin permeability. Pharmaceut Res 1992; 9:663-669.
47. Patel H, ten Berge W, Cronin MT. QSARs for prediction of skin permeation of exogenous chemicals. Chemosphere 2002; 48:603-613.
48. Patel H, Cronin M. Determination of the optimal physico-chemical parameters to use in a QSAR-approach to predict skin permeation rate. Final report. European Chemical Industry Council Long-range Research Initiative, CEFIC-LRI Project No. NMALRI-A2.2UNJM-0007; 2001(http://www.staff.livjm.ac.uk/ phamcron/qsar/CEFIC/final%20report.pdf).
49. Lian G, Chen L, Han L. An evaluation of mathematical models for predicting skin permeability. J Pharm Sci 2008; 97:584-598.
50. OECD. OECD guideline for the testing of chemicals. Skin absorption: in vitro method. Paris: OECD publishing; 2004, 427:1-8.
51. Van de Sandt JJM, Dellarco M, Van Hemmen JJ. From dermal exposure to internal dose. J Expo Sci Environ Epidemiol 2007; 1-10.
52. Williams FM. EDETOX. Evaluations and predictions of dermal absorption of toxic chemicals. Int Arch Occup Environ Health 2004; 77:150-151.
53. World Health Organization. Environmental Health Criteria 235. Dermal absorption. WHO/IPCS, Geneva, Switzerland.
54. U.S. EPA. Dermal exposure assessment: principles and applications. Washington, D.C., U.S. Environmental Protection Agency, Office of Environmental Assessment; 1992, EPA/600/8-91/011B.
55. Cleek RL, Bunge AL. A new method for estimating dermal absorption from chemical exposure. I. General approach. Pharm Res 1993; 10:497-503.
56. Poulin P, Krishnan K. Molecular structure-based prediction of human abdominal skin permeability coefficients for several organic compounds. J Toxicol Environ Health A 2001; 62:143-59.
57. Ursin C, Hansen CM, Van Dyk JW, Jensen PO, Christensen IJ, Ebbehoej J. Permeability of commercial solvents through living human skin. Am Ind Hyg Assoc J 1995; 56:651-660.
58. Schuhmacher-Wolz U, Kalberlah F, Oppl R, Van Hemmen JJ. A toolkit for dermal risk assessment: Toxicological approach for hazard characterization. Ann Occup Hyg 2003; 47:641-652.
59. Wilschut A, ten Berge WF, Robinson PJ, McKone TE. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995; 30:1275-1296.